steel domestic consumption decrease which suffered from slow down economics. Other income 21.9 27.7 26.6% A gain and profit in exchange rate comparing to the same period of last year due to efficient

Margin (%) 2.40 2.35 3.32 Current Ratio (Times) 1.43 1.43 1.46 Debt to Equity Ratio (Times) 1.79 1.81 1.72 Book Value per Share (Baht) 2.22 2.25 2.41 Net Profit per Share (Baht) 0.45 0.43 0.15 Interim

baht or 23.08% increased due to the payment through banking of plastic granule purchased (TR) . 7. Share of profit (loss) from investment in associated company For Quarter1 of the year 2019, Share of

Net Profit Margin (%) 2.40 2.35 3.13 Current Ratio (Times) 1.43 1.43 1.44 Debt to Equity Ratio (Times) 1.79 1.81 1.76 Book Value per Share (Baht) 2.22 2.25 2.31 Net Profit per Share (Baht) 0.45 0.43

 Profits decreased 4% to THB 517m in Q2 2018 from THB 539m in Q2 2017. Net Profit decreased 60% to THB 270m in Q218 from THB 676m in Q217, due to a foreign exchange loss of THB 236m in Q218 versus a foreign

28.12 Net Profit Margin (%) 2.35 3.18 3.68 Current Ratio (Times) 1.43 1.51 1.29 Debt to Equity Ratio (Times) 1.81 1.48 1.83 Book Value per Share (Baht) 2.25 2.39 2.56 Net Profit per Share (Baht) 0.43 0.57

export branded business, despite a decrease in export CMG and domestic branded.  Net profit in Q4/2017 was Baht 28 million, a decrease of 76% YoY due to 1) lower sales contribution of export pressuring

income 47.97 100.00 79.46 100.00 (39.63) Costs 18.79 39.17 42.14 53.03 (55.41) Administrative expenses, finance costs and share of loss from associates 37.52 78.22 29.56 37.20 26.93 Management benefit

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

products as well as growth from some exiting products. Domestic branded was quite maintained.  Net profit in Q1/2018 was Baht 9 million, a decrease of 92% YoY due to 1) lower sales contribution of export